In the context of tumors, EZH2 is often overexpressed and associated with aggressive cancer phenotypes, metastasis, and poor prognosis, where it promotes tumor growth by silencing tumor suppressor genes and dysregulating various signaling pathways [76]. The gene discussed is EZH2; the disease is cancer.